Cladribine an Alternative for Midostaurine in FLT3 Positive Acute Myeloid Leukemia
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 4
Abstract
Midostaurinis registered for the indication newly diagnosed acute myeloid leukemia that is FLT3 mutation positive in combination with standard cytarabine and daunorubicine induction and cytarabine consolidation. The registration is based on a study of 717 patients that examined the addition of midostaurin 50 mg orally twice daily or placebo to standard induction on days 8 to 21 of a cycle for a maximum of two induction cycles.
Authors and Affiliations
Marlies EHM Van Hoef
Keywords
Related Articles
- EP ID EP404339
- DOI 10.23880/hij-16000134
- Views 114
- Downloads 0
Resolving Serological Blood Group Discrepancy and Providing Transfusion Support in a Patient of Mixed Auto Immune Hemolytic Anemia: A Case Report
ABO grouping should include both forward and reverse grouping procedure, and results of two procedures should agree with each other. Mixed autoimmune hemolytic anemia (AIHA) is defined as presence of both warm and cold a...
Incidental Detection of Sickle Cell Anaemia as a Significant Haematological Problem in an Island Based Population
1.1. Introduction: Sickle cell anaemia is a haematological disease with a known gentic cause. However, there is paucity of data regarding this condition from islands of the world. Also there is no previous study in which...
Physicians’ Opinion on the Practice of Exchange Blood Transfusion for Treatment of Stroke in Sickle Cell Anaemia
1.1. Background: The current most effective preventive as well as therapeutic modality for stroke in sickle cell anaemia (SCA) is the use of exchange blood transfusion (EBT) in a chronic transfusion program. The challeng...
The Role of Uric Acid in Carbohydrate Metabolism among Hypertensive Individuals
The association between fasting blood glucose and insulin and serum uric acid levels in general population, as well as the positive association between serum uric acid levels and development of type 2 diabetes mellitus h...
Iatrogenic Cushing’s Syndrome with Secondary Adrenal Suppression Misdiagnosed as Protease Inhibitor-Induced Lipodystrophy in an HIV Positive Patient: Case Report
1.1. Background: Ritonavir is a commonly prescribed protease inhibitor (PI) which is used in low doses to boost levels of other protease inhibitors pharmacokinetically. It is a potent inhibitor of hepatic cytochrome P450...